tiprankstipranks
Advertisement
Advertisement

TTRX Stock Latest News

Turn Therapeutics Highlights GX-03 Phase 2 Atopic Dermatitis Data
Company AnnouncementsTurn Therapeutics Highlights GX-03 Phase 2 Atopic Dermatitis Data
1M ago
8K
TTRX
Turn announces interim analysis findings from Phase 2 trial of GX-03
PremiumThe Fly
Turn announces interim analysis findings from Phase 2 trial of GX-03
1M ago
TTRX
Turn Therapeutics Reports Positive Interim Phase 2 GX-03 Data
PremiumCompany Announcements
Turn Therapeutics Reports Positive Interim Phase 2 GX-03 Data
1M ago
8K
TTRX
Turn Therapeutics announces peer-reviewed article on GX-03
PremiumThe Fly
Turn Therapeutics announces peer-reviewed article on GX-03
1M ago
TTRX
Turn Therapeutics highlights GX-03 preclinical data in dermatitis
PremiumCompany Announcements
Turn Therapeutics highlights GX-03 preclinical data in dermatitis
1M ago
8K
TTRX
Turn Therapeutics CEO to Present at Jefferies Conference
PremiumCompany AnnouncementsTurn Therapeutics CEO to Present at Jefferies Conference
2M ago
8K
TTRX
Turn Therapeutics Appoints Former FDA Chief to Lead GX-03
Premium
Company Announcements
Turn Therapeutics Appoints Former FDA Chief to Lead GX-03
2M ago
8K
TTRX
Turn appoints Hahn as Executive Clinical, Regulatory Lead for GX-03
Premium
The Fly
Turn appoints Hahn as Executive Clinical, Regulatory Lead for GX-03
2M ago
TTRX
Turn Therapeutics reports Q1 EPS (3c) vs. (1c) last year
PremiumThe Fly
Turn Therapeutics reports Q1 EPS (3c) vs. (1c) last year
2M ago
TTRX
Turn Therapeutics reports FY25 EPS (12c) vs. (7c) last year
PremiumThe Fly
Turn Therapeutics reports FY25 EPS (12c) vs. (7c) last year
3M ago
TTRX
Turn Therapeutics Secures Growth Capital to Advance Dermatology
PremiumCompany Announcements
Turn Therapeutics Secures Growth Capital to Advance Dermatology
3M ago
8K
TTRX
Turn Therapeutics secures up to $25M in financing
PremiumThe Fly
Turn Therapeutics secures up to $25M in financing
3M ago
TTRX
Turn Therapeutics Appoints Robert Redfield as Senior Advisor
PremiumCompany AnnouncementsTurn Therapeutics Appoints Robert Redfield as Senior Advisor
5M ago
8K
TTRX
Turn Therapeutics Highlights GX-03 Progress at Investor Conferences
Premium
Company Announcements
Turn Therapeutics Highlights GX-03 Progress at Investor Conferences
5M ago
8K
TTRX
Turn Therapeutics Advances GX-03 Eczema Trial, Opening a New Catalyst for Investors
Premium
Company Announcements
Turn Therapeutics Advances GX-03 Eczema Trial, Opening a New Catalyst for Investors
5M ago
TTRX
Speculative Buy on Turn Therapeutics: Proprietary Platform, Capital-Efficient Growth, and 2026 Milestones as Key Upside Catalysts
PremiumRatings
Speculative Buy on Turn Therapeutics: Proprietary Platform, Capital-Efficient Growth, and 2026 Milestones as Key Upside Catalysts
6M ago
TTRX
Turn Therapeutics Issues Corporate, Pipeline and Financial Updates
PremiumCompany Announcements
Turn Therapeutics Issues Corporate, Pipeline and Financial Updates
6M ago
8K
TTRX
Turn Therapeutics appoints veteran executive to board
PremiumCompany Announcements
Turn Therapeutics appoints veteran executive to board
6M ago
8K
TTRX
Midday Fly By: SoftBank buying DigitalBridge, Verisk drops AccuLynx deal
PremiumThe Fly
Midday Fly By: SoftBank buying DigitalBridge, Verisk drops AccuLynx deal
6M ago
KKR
NVO
Turn Therapeutics initiated with a Buy at D. Boral Capital
PremiumThe FlyTurn Therapeutics initiated with a Buy at D. Boral Capital
6M ago
TTRX
Turn Therapeutics reports Q3 EPS (7c) vs (3c) last year
Premium
The Fly
Turn Therapeutics reports Q3 EPS (7c) vs (3c) last year
8M ago
TTRX
Turn Therapeutics’ GX-03 Recognized for Dermatology Innovation
Premium
Company Announcements
Turn Therapeutics’ GX-03 Recognized for Dermatology Innovation
8M ago
8K
TTRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >